By Erik Sass, TES Editor-in-Chief Following is a compilation of randomized controlled trials (and other types of studies) of hydroxychloroquine as a treatment for COVID-19, listing the flaws and errors which invalidate their conclusions. To add a trial entry or send corrections, please email TES Editor-in-Chief Erik Sass: eriksass@gmail.com . Boulware, et al. […]
Tag: hydroxychloroquine
Washington Beyond the Headlines: Deregulation = Gourmet Eats At Highway Rest Stops
By Andy Blom, TES Washington Editor I think what we really need is a baseball season, or some first-run movies. Well, if we have to deal with politics, Free Market policy people are working to offer better perspectives and policy options for the problems of the day. Here’s this week’s news … Leading […]
Hydroxychloroquine vs. COVID-19
HYDROXYCHLOROQUINE Research Bibliography & Digest The Economic Standard is gathering medical research about hydroxychloroquine as a treatment for COVID-19, alone or in combination with other drugs, published (or about to be published) in academic journals. Have a study? Submit citations with brief summaries, ideally from the text itself, via the submissions box below the […]
Putting Trump’s Treatment in Context
By Erik Sass, TES Editor-in-Chief On May 18, President Trump announced that he began taking a combination of hydroxychloroquine (HCQ), azithromycin, and zinc about 10 days prior. This was around the same time that multiple White House staffers were reported to have contracted the novel coronavirus. The President appears to be taking this […]
Bright vs. WHO: America Is Out of Step with the World on COVID-19 Treatment
By Erik Sass, Editor-in-Chief Sometimes the strange state of our reality can be summed up by two juxtaposed news items. Take this week’s bizarre exercise in cognitive dissonance: On the one hand, Rick Bright, the former director of the Biomedical Advanced Research and Development Authority, took a victory lap in front of Congress for […]
Promising COVID-19 Treatment Faces Political Hurdles
Hydroxychloroquine (HCQ) is part of recommended treatment for COVID-19 in modern healthcare systems around the world, and every day brings new evidence that appears to support this judgment call by overseas public health authorities. Sadly the U.S. is the only country on earth where the drug has become a toxic political football — due entirely […]
Partisan Food Fight Hobbles COVID-19 Treatment Research
By Erik Sass, Editor-in-Chief The U.S. debate over chloroquine (CQ) and hydroxychloroquine (HCQ) has become highly politicized. Ever since President Trump first mentioned the drugs on March 19 as a potential treatments for COVID-19, views of the issue have been polarized along familiar partisan lines. This may be due to Trump using […]
Buyer Beware: The Web Is Awash with Fake Chloroquine Products
By Roger Bate, American Enterprise Institute Chloroquine products are in high demand since President Trump touted them as possible treatment for the coronavirus in March. Original research done by the Safe Medicines Coalition, of which I’m a member, shows that fake versions of these products have reached the US market via rogue web […]
Forbes: Gates pursuing 7 vaccines, Contact tracing & Treatment controversy
In his “What’s Ahead” podcast, Steve Forbes shares his latest takes on a country increasingly shaped by the fight against COVID-19. Bill Gates is setting an example for the federal government in the urgency and agility of his response. Forbes notes that Gates is pursuing seven different vaccines and simultaneously building factories to […]
CNN: Balancing the benefits and risks of hydroxychloroquine
Dr. Jeff Colyer was featured in a story on CNN.com by Marshall Cohen on balancing the benefits and risks of treating COVID-19 patients with hydroxychloroquine: Former Kansas Gov. Jeff Colyer, now a surgeon in the Kansas City area who is treating patients with Covid-19, applauded the FDA’s decision to let hospitals use the […]